Vice President of Business Development

Vice President, Business Development – In-Licensing (Advanced Biologics)

Our client, a leading biopharmaceutical company, is seeking a seasoned and strategic Vice President of Business Development to lead global in-licensing efforts for advanced biologics, with a particular focus on antibody-based therapies. This executive will play a critical role in expanding the client’s pipeline by identifying and securing transformative assets across late clinical development stages.

Key Responsibilities:

• Define and execute the in-licensing strategy for advanced biologics, focusing on innovative antibody therapeutics including monoclonal antibodies, bispecifics, ADCs, and other next-generation modalities.
• Scout, evaluate, and prioritize global opportunities that align with the client’s scientific and commercial objectives.
• Cultivate and maintain strategic relationships with biotech companies, academic institutions, and key industry players to source high-potential assets.
• Lead all phases of the deal process, from sourcing and due diligence to negotiation and execution.
• Collaborate with internal stakeholders across R&D, Commercial, Regulatory, Finance, and Legal to assess strategic fit and value.
• Deliver strategic recommendations to the executive leadership team and key decision-makers.
• Represent the client at major partnering, scientific, and industry events to increase visibility and build a strong network.

Ideal Candidate:

• 15 years of experience in business development, licensing, or strategic partnerships within the biopharma industry, with a strong focus on advanced biologics and antibody-based platforms.
• Deep knowledge of biologic drug development, antibody engineering, and immunology.
• Demonstrated success in sourcing, structuring, and closing complex licensing and collaboration deals.
• Strong strategic acumen and the ability to influence high-level decision-making.
• Collaborative leadership style and excellent cross-functional communication skills.
• Advanced degree in life sciences (PhD, MD, or equivalent preferred); MBA is an asset.